CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Neoleukin Therapeutics Inc Company Snapshot
Neoleukin Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neoleukin Therapeutics Inc with three other companies in this sector in the United States: Bioanalytical Systems, Inc. (2018 sales of $26.35 million ), argenx SE ($25.31 million of which 53% was Milestone Payments), and Applied Genetic Technologies Corp ($24.19 million ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Neoleukin Therapeutics Inc
  Stock Performance Chart for Neoleukin Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 8.20
(Figures in U.S. Dollars)
1 Week 102.0%   13 Weeks 187.7%  
4 Weeks 132.3%   52 Weeks 258.1%  
 
Neoleukin Therapeutics Inc Key Data:
  Ticker: NLTX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 25,000,000
(Year Ending Jan 2019).
Employees: 8
  Currency: U.S. Dollars Market Cap: 230,749,993
  Fiscal Yr Ends: December Shares Outstanding: 28,140,243
  Share Type: Common Closely Held Shares: 71,566
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.